Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China
· Delayed Price · Currency is CNY 14.64
-0.28 (-1.88%)
Feb 28, 2025, 3:00 PM CST
SHA:600535 Revenue
In the year 2024, Tasly Pharmaceutical Group had annual revenue of 8.50B CNY, down -2.03%. Tasly Pharmaceutical Group had revenue of 2.04B in the quarter ending December 31, 2024, a decrease of -3.19%.
Revenue
8.50B
Revenue Growth
-2.03%
P/S Ratio
2.57
Revenue / Employee
921.41K
Employees
9,223
Market Cap
21.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.50B | -175.87M | -2.03% |
| Dec 31, 2023 | 8.67B | 36.58M | 0.42% |
| Dec 31, 2022 | 8.64B | 685.47M | 8.62% |
| Dec 31, 2021 | 7.95B | -5.62B | -41.43% |
| Dec 31, 2020 | 13.58B | -5.42B | -28.54% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| Jiangsu Hengrui Medicine | 26.00B |
| WuXi AppTec | 38.50B |
| Aier Eye Hospital Group | 20.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Shanghai United Imaging Healthcare | 10.93B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Sichuan Biokin Pharmaceutical | 5.85B |